Wikidata

(Q71403909)

English

Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group

scientific article published on 01 August 1996

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8759894
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8759894%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 October 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q71403909&oldid=2223001820"